Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bezafibrate add-on crossover trial in familial dysbetalipoproteinemia
NL-OMON43954Phase 4Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bezafibrate in dysbetalipoproteinemia (DBL), sponsored by Amsterdam University Medical Center. Primary endpoint: Difference in post-fat-load non-HDL cholesterol. Started Nov 2015; status: active, not recruiting.
02
Drugs
bezafibrate
03
Conditions
dysbetalipoproteinemia (DBL)
Beyond the preview
Go deeper on NL-OMON43954.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43954.